Access cutting-edge metastatic castration resistant prostate cancer (mcrpc) treatment through this clinical trial at a research site in Fairway. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Fairway location
Preparing your pre-screening questions…
Access metastatic castration resistant prostate cancer (mcrpc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metastatic castration resistant prostate cancer (mcrpc) treatment provided free
Check if you qualify for this metastatic castration resistant prostate cancer (mcrpc) clinical trial in Fairway, KS
No-Cost Study Care
Local to Fairway
Convenient for KS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC) and Follicular Lymphoma (FL). The study consists of 3 parts; Part 1 and 2 enrolled participants with SCLC, metastatic CRPC, and FL are closed for enrollment. Part 3, which is open for enrollment is seeking men who: * have Castration Resistant Prostate Cancer (CRPC) and * have previously received treatment for CRPC and have progressed from the last treatment All participants in Part 3 of this study will receive mevrometostat and/ or enzalutamide. Part 3 consists of 2 sub studies each has an assessment phase and a maintenance phase. The Part 3 DDI substudy consist of 2 cohorts, Cohort 1 (monotherapy cohort) and Cohort 2 (Combination cohort). In the assessment phase: * participants in the BE substudy will take 3 single doses of mevrometostat by mouth over 3 periods. * participants in the DDI substudy Cohort 1 (monotherapy cohort) will take mevrometostat 2 times a day and/or itraconazole 1 time a day based on a present schedule. * participants in the DDI substudy Cohort 2 (combination cohort) will take mevrometostat 2 times a day, enzalutamide 1 time a day, and/or itraconazole 1 time a day based on a present schedule. After completion of the assessment phase, participants will enter the maintenance phase where they will receive mevrometostat 2 times a day and enzalutamide 1 time a day by mouth until their cancer is no longer responding. The study will look at the experiences of participanrs receiving the study medicine. This will help see if the study medicine is safe and effective.
Sponsor: Pfizer
Yes, this clinical trial (NCT03460977) has an active research site in Fairway, KS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for metastatic castration resistant prostate cancer (mcrpc) treatment options in Fairway, KS, this clinical trial (NCT03460977) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairway research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic castration resistant prostate cancer (mcrpc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all metastatic castration resistant prostate cancer (mcrpc) clinical trials near you to find additional studies recruiting in your area.
See all prostate cancer clinical trials recruiting in Fairway — not just this study.
Browse Prostate Cancer Trials in Fairway →